The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,4-difluoro-N3-(3-(4-fluorophenylcarbamoyl)-1H-pyrazol-4-yl)-N3'-((1-methylpiperidin-4-yl)methyl)biphenyl-3,3'-dicarboxamide ID: ALA4795774
PubChem CID: 162673993
Max Phase: Preclinical
Molecular Formula: C31H29F3N6O3
Molecular Weight: 590.61
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCC(CNC(=O)c2cccc(-c3ccc(F)c(C(=O)Nc4c[nH]nc4C(=O)Nc4ccc(F)cc4)c3F)c2)CC1
Standard InChI: InChI=1S/C31H29F3N6O3/c1-40-13-11-18(12-14-40)16-35-29(41)20-4-2-3-19(15-20)23-9-10-24(33)26(27(23)34)30(42)38-25-17-36-39-28(25)31(43)37-22-7-5-21(32)6-8-22/h2-10,15,17-18H,11-14,16H2,1H3,(H,35,41)(H,36,39)(H,37,43)(H,38,42)
Standard InChI Key: HHNHVDQBIIAJOM-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 47 0 0 0 0 0 0 0 0999 V2000
32.0713 -3.9704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0701 -4.7899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7782 -5.1989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4878 -4.7894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4850 -3.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7764 -3.5615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1962 -5.1969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1975 -6.0141 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.9033 -4.7872 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6116 -5.1947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6964 -6.0053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4960 -6.1740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.9036 -5.4656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.3557 -4.8593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5231 -4.0594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2995 -3.8044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9141 -3.5145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.1912 -3.5555 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.0814 -2.7146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8572 -2.4640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0247 -1.6650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4154 -1.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6358 -1.3780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4719 -2.1764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3640 -5.1982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6563 -4.7873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9488 -5.1947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9477 -6.0128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6601 -6.4218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3647 -6.0121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5817 -0.3191 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.7780 -6.0160 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
29.2416 -4.7852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5334 -5.1929 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.2426 -3.9680 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9509 -3.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9519 -2.7431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6637 -2.3364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6667 -1.5228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9613 -1.1095 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2513 -1.5160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2466 -2.3357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9654 -0.2923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
14 15 1 0
15 16 2 0
15 17 1 0
5 18 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
2 25 1 0
22 31 1 0
3 32 1 0
27 33 1 0
33 34 2 0
33 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
37 42 1 0
38 39 1 0
39 40 1 0
40 41 1 0
41 42 1 0
40 43 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 590.61Molecular Weight (Monoisotopic): 590.2253AlogP: 5.07#Rotatable Bonds: 8Polar Surface Area: 119.22Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.51CX Basic pKa: 8.89CX LogP: 3.94CX LogD: 2.76Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.23Np Likeness Score: -1.50
References 1. Lin T,Li J,Liu L,Li Y,Jiang H,Chen K,Xu P,Luo C,Zhou B. (2021) Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors., 215 [PMID:33611192 ] [10.1016/j.ejmech.2021.113281 ]